Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page
- Check3 days agoChange DetectedHead and neck squamous cell carcinoma and the related topic MedlinePlus Genetics were removed from the page's related topics. This affects how the study is categorized and surfaced in topic-based searches.SummaryDifference0.2%

- Check10 days agoChange DetectedMedlinePlus Genetics related topics: Head and neck squamous cell carcinoma was added to the page. This provides an external consumer health information link but does not affect the study details.SummaryDifference0.9%

- Check24 days agoChange DetectedAdds a new MedlinePlus Genetics topic on head and neck squamous cell carcinoma to the page content.SummaryDifference0.4%

- Check31 days agoChange DetectedUpdated the page to v3.2.0 and added a government-operating-status notice; removed the v3.1.0 reference.SummaryDifference3%

- Check38 days agoChange DetectedReworded naming from 'Head and neck squamous cell carcinoma' to 'Squamous cell carcinoma of the head and neck' and updated the revision version to v3.1.0. No new content or data added; alignment to a different naming convention with an accompanying version bump.SummaryDifference0.6%

- Check53 days agoChange DetectedUpdated to revision v3.0.2 (replacing v3.0.1). The MedlinePlus Genetics topic 'Head and neck squamous cell carcinoma' was removed, and the 'Back to Top' link along with the old revision note were also deleted, indicating a targeted content prune with a version bump.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.